ロード中...
Evidence that rifampicin can be used safely for non-tuberculous diseases.
The incidence of primary resistance to rifampicin in Mycobacterium tuberculosis has been analysed in countries where rifampicin is restricted to use for treating tuberculosis and in countries where its use is not restricted. There is no evidence that rifampicin-resistant M tuberculosis strains are m...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1980
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC471381/ https://ncbi.nlm.nih.gov/pubmed/6781092 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|